Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐acting β2‐adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor‐mediated transcription in human airway epithelial cells in a gene‐ and agonist‐dependent manner

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2634-2653

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults

By Setyawan Juliana   Hodgkins Paul   Guérin Annie   Gauthier Geneviève   Cloutier Martin   Wu Eric   Erder M. Haim  

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1203-1215

Informa Healthcare

Access to resources Recommend Favorite

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

By Snowise Neil G.   Clements Diane   Ho Shu-Yen   Follows Richard M.A.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1663-1674

Informa Healthcare

Access to resources Recommend Favorite

Effects of chronic treatment with the new ultra‐long‐acting β2‐adrenoceptor agonist indacaterol alone or in combination with the β1‐adrenoceptor blocker metoprolol on cardiac remodelling

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3627-3637

John Wiley & Sons Inc

Access to resources Recommend Favorite